Patent · US Active

Multiple kinase pathway inhibitors

US9493454B2 · kind B2 · utility

10Cited by

3References

24Claims

0Family size

Assignees

TOLERO PHARMACEUTICALS, INC. · US
MannKind Corporation · US

Inventors

Qingping Zeng · Thousand Oaks, US
Mary Faris · Los Angeles, US
Alexis Henri Abel Mollard · Salt Lake City, US
Steven L. Warner · Sandy, US
Gary A. Flynn · Cincinnati, US

Key dates

Filing date	Sep 25, 2013
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Sep 25, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Kinase with inhibitory activity against kinases disposed in multiple signaling pathways and their therapeutic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.